Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for PLCO

Publication Year
Title PubMed Authors Journal Year Studies
Genome-wide association study identifies new prostate cancer susceptibility loci. 21743057 Schumacher FR, Berndt SI, Siddiq A, Jacobs KB, Wang Z, Lindstrom S, Stevens VL, Chen C, Mondul AM, Travis RC, Stram DO, Eeles RA, Easton DF, Giles G, Hopper JL, Neal DE, Hamdy FC, Donovan JL, Muir K, Al Olama AA, Kote-Jarai Z, Guy M, Severi G, Grönb… Hum. Mol. Genet. 2011 PLCO
Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. 21602798 Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, Diver WR, Witte JS, Hsing AW, Nemesure B, Rebbeck TR, Cooney KA, Xu J, Kibel AS, Hu JJ, John EM, Gueye SM, Watya S, Signorello LB, Hayes RB,… Nat. Genet. 2011 PLCO
Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels. 21318478 Parikh H, Wang Z, Pettigrew KA, Jia J, Daugherty S, Yeager M, Jacobs KB, Hutchinson A, Burdett L, Cullen M, Qi L, Boland J, Collins I, Albert TJ, Vatten LJ, Hveem K, Njølstad I, Cancel-Tassin G, Cussenot O, Valeri A, Virtamo J, Thun MJ, Feigelson HS… Hum. Genet. 2011 PLCO
No effect of meat, meat cooking preferences, meat mutagens or heme iron on lung cancer risk in the prostate, lung, colorectal and ovarian cancer screening trial. 20232386 Tasevska N, Cross AJ, Dodd KW, Ziegler RG, Caporaso NE, Sinha R Int. J. Cancer 2011 PLCO
N-acetyltransferase 2 polymorphisms, tobacco smoking, and breast cancer risk in the breast and prostate cancer cohort consortium. 22074863 Cox DG, Dostal L, Hunter DJ, Le Marchand L, Hoover R, Ziegler RG, Thun MJ, Breast and Prostate Cancer Cohort Consortium Am. J. Epidemiol. 2011 PLCO
Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry. 21998595 N'Diaye A, Chen GK, Palmer CD, Ge B, Tayo B, Mathias RA, Ding J, Nalls MA, Adeyemo A, Adoue V, Ambrosone CB, Atwood L, Bandera EV, Becker LC, Berndt SI, Bernstein L, Blot WJ, Boerwinkle E, Britton A, Casey G, Chanock SJ, Demerath E, Deming SL, Diver… PLoS Genet. 2011 PLCO
Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. 21131975 Purdue MP, Johansson M, Zelenika D, Toro JR, Scelo G, Moore LE, Prokhortchouk E, Wu X, Kiemeney LA, Gaborieau V, Jacobs KB, Chow WH, Zaridze D, Matveev V, Lubinski J, Trubicka J, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Bucur A, Be… Nat. Genet. 2011 PLCO
Hormone-related risk factors and postmenopausal breast cancer among nulliparous versus parous women: An aggregated study. 21266505 Schonfeld SJ, Pfeiffer RM, Lacey JV, Berrington de González A, Doody MM, Greenlee RT, Park Y, Schairer C, Schatzkin A, Sigurdson AJ, Hartge P, Visvanathan K Am. J. Epidemiol. 2011 PLCO
Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. 20929901 Sigurdson AJ, Jones IM, Wei Q, Wu X, Spitz MR, Stram DA, Gross MD, Huang WY, Wang LE, Gu J, Thomas CB, Reding DJ, Hayes RB, Caporaso NE Carcinogenesis 2011 PLCO
Dietary carbohydrate, glycemic index, glycemic load, and risk of prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. 21553078 Shikany JM, Flood AP, Kitahara CM, Hsing AW, Meyer TE, Willcox BJ, Redden DT, Ziegler RG Cancer Causes Control 2011 PLCO
Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer. 21685357 Pine SR, Mechanic LE, Enewold L, Chaturvedi AK, Katki HA, Zheng YL, Bowman ED, Engels EA, Caporaso NE, Harris CC J. Natl. Cancer Inst. 2011 PLCO
Intra-individual variability over time in serum cytokine levels among participants in the prostate, lung, colorectal, and ovarian cancer screening Trial. 21764327 Hofmann JN, Yu K, Bagni RK, Lan Q, Rothman N, Purdue MP Cytokine 2011 PLCO
Genetic variation on 9p22 is associated with abnormal ovarian ultrasound results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. 21750727 Wentzensen N, Black A, Jacobs K, Yang HP, Berg CD, Caporaso N, Peters U, Ragard L, Buys SS, Chanock S, Hartge P PLoS ONE 2011 PLCO
Potential role of HE4 in multimodal screening for epithelial ovarian cancer. 21917606 Urban N, Thorpe JD, Bergan LA, Forrest RM, Kampani AV, Scholler N, O'Briant KC, Anderson GL, Cramer DW, Berg CD, McIntosh MW, Hartge P, Drescher CW J. Natl. Cancer Inst. 2011 PLCO
Building multi-marker algorithms for disease prediction-the role of correlations among markers. 21918599 Pinsky PF, Zhu CS Biomark Insights 2011 PLCO
A prospective evaluation of C-reactive protein levels and colorectal adenoma development. 21212059 Gunter MJ, Cross AJ, Huang WY, Stanczyk FZ, Purdue M, Xue X, Schoen R, Limburg PJ, Schatzkin A, Sinha R, Hayes RB Cancer Epidemiol. Biomarkers Prev. 2011 PLCO
The use of imputed values in the meta-analysis of genome-wide association studies. 21769935 Jiao S, Hsu L, Hutter CM, Peters U Genet. Epidemiol. 2011 PLCO
The landscape of recombination in African Americans. 21775986 Hinch AG, Tandon A, Patterson N, Song Y, Rohland N, Palmer CD, Chen GK, Wang K, Buxbaum SG, Akylbekova EL, Aldrich MC, Ambrosone CB, Amos C, Bandera EV, Berndt SI, Bernstein L, Blot WJ, Bock CH, Boerwinkle E, Cai Q, Caporaso N, Casey G, Cupples LA, … Nature 2011 PLCO
A special program to increase the participation of Hispanics in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Tenorio SL, Gamito EJ, Ogden S, Quintela J, Ordonez E, Crawford ED, Lamerato L Hisp Health Care Int 2011 PLCO
Evaluation of multiplexed cytokine and inflammation marker measurements: a methodologic study. 21715603 Chaturvedi AK, Kemp TJ, Pfeiffer RM, Biancotto A, Williams M, Munuo S, Purdue MP, Hsing AW, Pinto L, McCoy JP, Hildesheim A Cancer Epidemiol. Biomarkers Prev. 2011 PLCO